Summary
- Current Price
- As of today, ABUS price is $4.54, down -1.73% on
- Current Price All-Time High
- ABUS price is currently -85.58% below its historical high of $31.48 set on
- Market Cap
- ABUS current market cap is $897M, up +37.64% over the past 365 days
- PE Ratio
- ABUS current PE ratio is 5.52
- Revenue
- ABUS current annual revenue is $14.08M, up +128.21% year-over-year
- Next Earnings
- As of today, the next earnings release for ABUS has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Arbutus Biopharma Corporation |
| Ticker | NASDAQ: ABUS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | arbutusbio.com |
| Employees | 44 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $4.54 | |
| Price, 1D Change | -1.73% | |
| $897M | ||
| - | ||
| 5.52 | ||
| 1.22 | ||
| $14.08M | ||
| Revenue, 1Y Change | +128.21% | |
| -$0.17 | ||
| EPS, 1Y Change | +53.60% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:5 | |
| Next Split | N/A | N/A |
| Last Ticker Change | TKMR | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.17 | ||
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| $14.08M | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $4.54 | |
| Price Target | $5.51 | - |
| Price Tgt. Change | +21.34% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.44 | - | |
| - | -$0.38 | - | |
| - | -$0.17 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $18.14M | - | |
| - | $6.17M | - | |
| - | $14.08M | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $4.54 | |
| $4.45 | ||
| $4.52 | ||
| $4.35 | ||
| $4.51 | ||
| -$0.04 | ||
| 1.22 | ||
| $0.19 | ||
| 51.18 | ||
| 36.46% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $14.08M | ||
| -$0.17 | ||
| $13.72M | ||
| 97.42% | ||
| -$27.05M | ||
| -192.08% | ||
| -$33.50M | ||
| -237.88% | ||
| -$26.69M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.05 | ||
| 15.73 | ||
| 15.73 | ||
| - | ||
| 6 | ||
| 9.73 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 5.52 | ||
| 4.68 | ||
| 3.45 | ||
| 5.19 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $76.58M | ||
| $91.47M | ||
| $94.62M | ||
| $94.46M | ||
| $18.04M | ||
| $6.01M | ||
| $4.19M | ||
| $547.00K | ||
| $1.17M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $47.58M | ||
| $40.77M | ||
| $363.00K | ||
| $0.00 | ||
| $363.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$39.64M | ||
| $15.58M | ||
| $5.72M | ||
| $0.00 | ||
| -$39.64M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Chardan Capital | → | |
| Chardan Capital | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Jefferies | → | |
| JMP Securities | → |
Analyst sentiment
Institutional ownership
Screeners with ABUS
FAQ
- What is the ticker symbol for Arbutus Biopharma Corporation?
- The ticker symbol for Arbutus Biopharma Corporation is NASDAQ:ABUS
- Does Arbutus Biopharma Corporation pay dividends?
- No, Arbutus Biopharma Corporation does not pay dividends
- What sector is Arbutus Biopharma Corporation in?
- Arbutus Biopharma Corporation is in the Healthcare sector
- What industry is Arbutus Biopharma Corporation in?
- Arbutus Biopharma Corporation is in the Biotechnology industry
- What country is Arbutus Biopharma Corporation based in?
- Arbutus Biopharma Corporation is headquartered in United States
- When did Arbutus Biopharma Corporation go public?
- Arbutus Biopharma Corporation initial public offering (IPO) was on July 26, 2007
- Is Arbutus Biopharma Corporation in the S&P 500?
- No, Arbutus Biopharma Corporation is not included in the S&P 500 index
- Is Arbutus Biopharma Corporation in the NASDAQ 100?
- No, Arbutus Biopharma Corporation is not included in the NASDAQ 100 index
- Is Arbutus Biopharma Corporation in the Dow Jones?
- No, Arbutus Biopharma Corporation is not included in the Dow Jones index
- When was Arbutus Biopharma Corporation last earnings report?
- Arbutus Biopharma Corporation's most recent earnings report was on August 6, 2026
- When does Arbutus Biopharma Corporation report earnings?
- The date for Arbutus Biopharma Corporation's next earnings report has not been announced yet
Data Sources & References
- ABUS Official Website www.arbutusbio.com
- ABUS Profile on Yahoo Finance finance.yahoo.com/quote/ABUS
- ABUS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abus